United States

People: Illumina Inc (ILMN.O)

ILMN.O on Nasdaq

20 Oct 2017
Change (% chg)

$4.70 (+2.29%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Bowman, Arthur 

Mr. Arthur Blaine Bowman is Lead Independent Director of Illumina, Inc. since March 2016. He served as Independent Director between 2007 to 2016. Mr. Bowman was formerly the Chairman, President, and Chief Executive Officer of Dionex Corporation, a NASDAQ-listed manufacturer of analytical instruments. Mr. Bowman retired as President and Chief Executive Officer of Dionex in 2002 and as Chairman of the Board in 2005, and he remained a director of Dionex until its sale to Thermo Fisher Scientific Inc. in 2011. He joined Dionex in 1977 and was named President and Chief Executive Officer in 1980. Before joining Dionex, Mr. Bowman was a management consultant with McKinsey & Company, a management consulting firm, and a product engineer with Motorola Semiconductor Products Division, a communication equipment company. Mr. Bowman also serves as a director of Altera Corporation, a NASDAQ-listed provider of programmable logic solutions, and ProteinSimple, a privately-held life sciences company focused on protein research through the use of nanoproteomics. He also served as a past director of Molecular Devices Corporation, a NASDAQ-listed supplier of instruments and consumables for life science researchers, from 1985 until its sale to MDS Inc. in 2007, and of Solexa, Inc. from 2006 until its sale to Illumina in 2007. Mr. Bowman received his B.S. in Physics from Brigham Young University and an M.B.A. from Stanford University.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Awards, USD 400,076
Long-Term Incentive Plans, USD --
All Other, USD 114,490
Fiscal Year Total, USD 514,566

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Jay Flatley


Francis deSouza


Sam Samad


Marc Stapley


Garret Hampton


Omead Ostadan

As Of  31 Dec 2016